ATAI Life Sciences N.V’s recent filing unveils that its Chief Business Officer Kirpekar Sahil unloaded Company’s shares for reported $65560.0 on Mar 21 ’25. In the deal valued at $1.35 per share,48,563 shares were sold. As a result of this transaction, Kirpekar Sahil now holds 115,636 shares worth roughly $0.15 million.
Then, Craig Kevin James sold 11,563 shares, generating $15,610 in total proceeds. Upon selling the shares at $1.35, the Chief Medical Officer now owns 8,437 shares.
Before that, Rao Srinivas sold 75,418 shares. ATAI Life Sciences N.V shares valued at $101,814 were divested by the insider at a price of $1.35 per share. As a result of the transaction, Rao Srinivas now holds 212,942 shares, worth roughly $0.28 million.
H.C. Wainwright reiterated its ATAI Life Sciences N.V [ATAI] rating to a Buy in a research note published on November 18, 2024; the price target was $10. A number of analysts have revised their coverage, including Maxim Group’s analysts, who increased its forecast for the stock in early April from “a Hold” to “a Buy”. Loop Capital began covering ATAI with “Buy” recommendation on November 01, 2022. Maxim Group started covering the stock on November 30, 2021. It rated ATAI as “a Buy”.
Price Performance Review of ATAI
On Friday, ATAI Life Sciences N.V [NASDAQ:ATAI] saw its stock fall -0.38% to $1.31. Over the last five days, the stock has lost -10.88%. ATAI Life Sciences N.V shares have fallen nearly -1.50% since the year began. Nevertheless, the stocks have fallen -45.19% over the past one year. While a 52-week high of $2.85 was reached on 02/12/25, a 52-week low of $1.03 was recorded on 04/01/25. SMA at 50 days reached $1.6936, while 200 days put it at $1.4362.
Levels Of Support And Resistance For ATAI Stock
The 24-hour chart illustrates a support level at 1.2567, which if violated will result in even more drops to 1.2033. On the upside, there is a resistance level at 1.3567. A further resistance level may holdings at 1.4033. The Relative Strength Index (RSI) on the 14-day chart is 42.31, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0542, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 79.55%. Stochastics %K at 33.71% indicates the stock is a holding.
How much short interest is there in ATAI Life Sciences N.V?
A steep rise in short interest was recorded in ATAI Life Sciences N.V stocks on 2025-03-14, dropping by -0.76 million shares to a total of 10.4 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 11.16 million shares. There was a decline of -7.28%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on November 11, 2021 when ROTH Capital began covering the stock and recommended ‘”a Buy”‘ rating along with a $32 price target.
